ATF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.347000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.901200E-01
Normal-vs-Stage2
7.595800E-01
Normal-vs-Stage3
5.766000E-02
Normal-vs-Stage4
2.861600E-01
Stage1-vs-Stage2
9.118800E-01
Stage1-vs-Stage3
5.235600E-02
Stage1-vs-Stage4
1.144430E-01
Stage2-vs-Stage3
1.027630E-01
Stage2-vs-Stage4
6.919600E-02
Stage3-vs-Stage4
1.247510E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.889400E-01
Normal-vs-AfricanAmerican
6.656200E-01
Normal-vs-Asian
4.784400E-01
Caucasian-vs-AfricanAmerican
1.455010E-01
Caucasian-vs-Asian
3.591600E-01
AfricanAmerican-vs-Asian
1.665960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.256600E-01
Normal-vs-Female
7.530200E-01
Male-vs-Female
9.103400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.749600E-01
Normal-vs-Age(41-60Yrs)
8.579000E-01
Normal-vs-Age(61-80Yrs)
5.733800E-01
Normal-vs-Age(81-100Yrs)
3.078200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.554000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.338200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.946800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.042280E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.435600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.786600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.919400E-01
Normal-vs-Daily Drinker
2.373800E-01
Normal-vs-Weekly Drinker
6.953200E-01
Normal-vs-Occasional Drinker
8.838800E-01
Normal-vs-Social Drinker
9.033600E-01
Non Drinker-vs-Daily Drinker
5.155000E-01
Non Drinker-vs-Weekly Drinker
4.779800E-01
Non Drinker-vs-Occasional Drinker
6.544300E-02
Non Drinker-vs-Social Drinker
9.774400E-02
Daily Drinker-vs-Weekly Drinker
2.339400E-01
Daily Drinker-vs-Occasional Drinker
2.727900E-02
Daily Drinker-vs-Social Drinker
4.655500E-02
Weekly Drinker-vs-Occasional Drinker
3.771600E-01
Weekly Drinker-vs-Social Drinker
4.334800E-01
Occasional Drinker-vs-Social Drinker
9.856600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.256610E-01
Normal-vs-Grade 2
2.485800E-02
Normal-vs-Grade 3
2.601600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.010600E-01
Grade 1-vs-Grade 3
1.100950E-01
Grade 1-vs-Grade 4
1.256610E-01
Grade 2-vs-Grade 3
4.508400E-01
Grade 2-vs-Grade 4
2.485800E-02
Grade 3-vs-Grade 4
2.601600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.625800E-01
Normal-vs-NonDiabetic
6.093600E-01
Diabetic-vs-NonDiabetic
8.323800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.526000E-01
Normal-vs-NoPancreatitis
6.665400E-01
Pancreatitis-vs-NoPancreatitis
4.534400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.502400E-01
Normal-vs-N1
7.939200E-01
N0-vs-N1
4.013800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.042200E-01
Normal-vs-TP53-NonMutant
8.322400E-01
TP53-Mutant-vs-TP53-NonMutant
2.646600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
